These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

63 related items for PubMed ID: 1462037

  • 1. [The soluble IL-2 receptor in malignant hemopathies].
    Rupoli S, Montillo M, Salvi A, Brianzoni MF, Centurioni R, Cinciripini A, Paoletti P, Recchioni A, Leoni P.
    Recenti Prog Med; 1992 Oct; 83(10):546-51. PubMed ID: 1462037
    [Abstract] [Full Text] [Related]

  • 2. [Clinical significance of soluble interleukin-2 receptor in multiple myeloma].
    Akimoto Y, Ishiyama T, Ueno H, Hino K, Tomoyasu S, Tsuruoka N.
    Rinsho Ketsueki; 1995 Nov; 36(11):1247-51. PubMed ID: 8691563
    [Abstract] [Full Text] [Related]

  • 3. [Clinical significance of serum soluble interleukin-2 receptor level in patients with non-Hodgkin's lymphoma].
    Shimomura Y, Tsurumi H, Sawada M, Yamada T, Hara T, Fukuno K, Goto H, Moriwaki H.
    Rinsho Ketsueki; 1999 Aug; 40(8):639-45. PubMed ID: 10496038
    [Abstract] [Full Text] [Related]

  • 4. [Usefulness of the measurement of serum soluble IL-2 receptor alpha chain levels in clinical monitoring of non-Hodgkin lymphoma].
    Setoyama Y, Imai J, Ishikawa T, Sakaida H, Takaori-Kondo A, Kawamata S, Uchiyama T.
    Rinsho Byori; 1994 Aug; 42(8):834-42. PubMed ID: 7933620
    [Abstract] [Full Text] [Related]

  • 5. Serum soluble IL-2 receptor as a reliable and noninvasive marker of disease activity in patients with hairy cell leukemia.
    Chrobák L, Podzimek K, Plísková L, Kerekes Z, Zák P, Voglová J, Spacek J, Palicka V.
    Neoplasma; 1996 Aug; 43(5):321-5. PubMed ID: 8996552
    [Abstract] [Full Text] [Related]

  • 6. Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma.
    Boyano MD, Garcia-Vázquez MD, López-Michelena T, Gardeazabal J, Bilbao J, Cañavate ML, Galdeano AG, Izu R, Díaz-Ramón L, Raton JA, Díaz-Pérez JL.
    Br J Cancer; 2000 Oct; 83(7):847-52. PubMed ID: 10970683
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Detection of soluble IL-2 receptor in the serum and bone marrow of patients with minimal residual hematological malignancies: induction under therapy with IL-2.
    Kandefer-Szerszeń M, Legieć W, Dmoszyńska A, Rzeski W.
    Arch Immunol Ther Exp (Warsz); 1997 Oct; 45(5-6):443-8. PubMed ID: 9437500
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [The serum levels of soluble interleukin-2 receptor in patients with malignant lymphocytic proliferative disorders].
    Xu J, Wang B.
    Zhonghua Xue Ye Xue Za Zhi; 1998 Feb; 19(2):82-4. PubMed ID: 10921108
    [Abstract] [Full Text] [Related]

  • 11. Plasma soluble interleukin-2 receptor (sIL-2R) levels in patients with acute leukemia.
    Moon Y, Kim Y, Kim M, Lim J, Kang CS, Kim WI, Shim SI, Chung NG, Park YH, Min WS, Han K.
    Ann Clin Lab Sci; 2004 Feb; 34(4):410-5. PubMed ID: 15648782
    [Abstract] [Full Text] [Related]

  • 12. Serum levels of tumor necrosis factor and soluble interleukin 2 receptor as markers of disease activity and prognosis in childhood leukemia and lymphoma.
    Kalmanti M, Karamolengou K, Dimitriou H, Tosca A, Vlachonikolis I, Peraki M, Georgoulias V, Kalmantis T.
    Int J Hematol; 1993 Apr; 57(2):147-52. PubMed ID: 8494993
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Soluble interleukin-2 receptors in sera of children with primary malignant neoplasms.
    Bodey B, Psenko V, Lipsey AL, Kaiser HE.
    Anticancer Res; 1996 Apr; 16(1):219-24. PubMed ID: 8615612
    [Abstract] [Full Text] [Related]

  • 18. Serum levels of soluble interleukin-2 receptor (sIL-2R) in B-chronic lymphocytic leukemia.
    Cacciola E, Calogero D, Marra G, Guglielmo P.
    Boll Soc Ital Biol Sper; 1992 Apr; 68(4):259-62. PubMed ID: 1463600
    [Abstract] [Full Text] [Related]

  • 19. Constitutive secretion of soluble interleukin-2 receptor by human T cell lymphoma xenografted into SCID mice. Correlation of tumor volume with concentration of tumor-derived soluble interleukin-2 receptor in body fluids of the host mice.
    Wasik MA, Sioutos N, Tuttle M, Butmarc JR, Kaplan WD, Kadin ME.
    Am J Pathol; 1994 May; 144(5):1089-97. PubMed ID: 8178932
    [Abstract] [Full Text] [Related]

  • 20. Serum thymidine kinase and soluble interleukin-2 receptor predict recurrence of malignant lymphoma.
    Wakao D, Murohashi I, Tominaga K, Yoshida K, Kishimoto K, Yagasaki F, Itoh Y, Itoh K, Sakata T, Kawai N, Kayano H, Suzuki T, Matsuda A, Hirashima K, Bessho M.
    Ann Hematol; 2002 Mar; 81(3):140-6. PubMed ID: 11904739
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.